COMPANY

About Us

Cellogy is a biotechnology startup advancing stem cell-based modeling of human disease through quantitative imaging and machine learning. Cellogy’s first product, called Pulse, performs automated characterization of stem cell-derived cardiomyocytes using video microscopy and state-of-the-art computer vision analysis. In addition to Pulse, Cellogy is developing other innovative products to address the growing need for automated, large-scale analysis of stem cells and differentiated cells.

Leadership

kevin-image

Kevin Loewke, Ph.D.

Co-Founder and CEO

Prior to Cellogy, Kevin was a Co-Founder of Auxogyn, Inc., a venture-backed medical device startup in the field of reproductive health. He created and led development of Auxogyn's flagship product, Eeva, which uses time-lapse imaging and computer vision to predict the viability of pre-implantation human embryos during IVF procedures. Kevin received his Ph.D. from Stanford University and his Post-Doctoral training at the Stanford Institute for Stem Cell Biology and Regenerative Medicine.

mahnaz-image

Mahnaz Maddah, Ph.D.

Co-Founder and CTO

Mahnaz brings more than a decade of experience in image analysis to the company, with expertise in computer vision, machine learning, and product development. Prior to Cellogy, she worked at GE Global Research, SRI International, and Auxogyn Inc. as a computer vision scientist, where she designed and developed novel algorithms for different products, led projects, and played a key role in research studies. Mahnaz received her Ph.D. in electrical engineering and computer science from MIT.

Advisers

renee-image

Renee Reijo Pera, Ph.D.

Scientific Adviser and Board Director

Renee was the George D. Smith Professor of Stem Cell Cell Biology and Regenerative Medicine at Stanford University and directed the Center for Pluripotent Stem Cell Research and Education. She recently relocated to Montana State University in Bozeman, MT, where she serves as Vice President for Research and Economic Development.

bruce-image

Bruce Conklin, M.D.

Scientific Adviser

Bruce is an Investigator at the Gladstone Institute of Cardiovascular Disease and Professor of Genomic Medicine and Cellular and Molecular Pharmacology at the University of California, San Francisco.